国际眼科纵览

• 综述 • 上一篇    下一篇

玻璃体切除术后黄斑水肿的治疗

王贝贝 李秋明 董淑倩 胡芷柔   

  1. 郑州大学第一附属医院眼科 河南省眼科医院 450052
  • 收稿日期:2019-06-13 出版日期:2019-12-22 发布日期:2019-12-26
  • 通讯作者: 李秋明,Email: liqiuming63@163.com
  • 基金资助:

    国家自然科学基金(81800830)

Treatment of macular edema after vitrectomy

Wang Beibei, Li Qiuming, Dong Shuqian, Hu Zhirou   

  1. Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Henan Provincial Ophthalmic Hospital, Zhengzhou 450052, China
  • Received:2019-06-13 Online:2019-12-22 Published:2019-12-26
  • Contact: Li Qiuming, Email: liqiuming63@163.com
  • Supported by:

    National Natural Science Foundation of China (81800830)

摘要:

睫状体平坦部玻璃体切除术(pars plana vitrectomy, PPV)术后黄斑水肿(macular edema,ME)的发生严重影响患者的术后视力。糖皮质激素能够有效控制炎性反应,是目前治疗PPV术后炎症相关性ME的主要方法,可局部外用、球周注射,以及玻璃体注射长效或短效糖皮质激素。其他治疗方法还有手术解除黄斑区膜样牵拉、玻璃体注射抗血管内皮生长因子药物、局部应用非甾体抗炎药、口服碳酸酐酶抑制剂、皮下注射α-2a干扰素及外用倍他洛尔等。(国际眼科纵览,2019, 43: 366-372)

Abstract:

The occurrence of macular edema (ME) after pars plana vitrectomy (PPV) severely affects postoperative visual acuity. Corticosteroids can effectively control the inflammatory response. It is currently the main method for the treatment of inflammation\|related ME after PPV. It can be applied topically, peri\|injection, or intravitreal injection of long\|acting or short\|acting glucocorticoids. Other treatments include surgical removal of macular membrane\|like traction, vitreous injection of anti\|vascular endothelial growth factor(VEGF), topical application of non\|steroidal anti\|inflammatory drugs, oral carbonic anhydrase inhibitors, subcutaneous injection of alpha-2a interferon and topical betalol.(Int Rev Ophthalmol, 2019, 43: 366-372)